These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27112737)
21. Long-Term Effects of Metreleptin in Rabson-Mendenhall Syndrome on Glycemia, Growth, and Kidney Function. Okawa MC; Cochran E; Lightbourne M; Brown RJ J Clin Endocrinol Metab; 2022 Feb; 107(3):e1032-e1046. PubMed ID: 34718628 [TBL] [Abstract][Full Text] [Related]
22. Use of lispro insulin for treatment of diabetic ketoacidosis in dogs. Sears KW; Drobatz KJ; Hess RS J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):211-8. PubMed ID: 22390184 [TBL] [Abstract][Full Text] [Related]
23. Diabetic ketoacidosis, hyperuricemia and encephalopathy intractable to regular-dose insulin. Gregory J; Basu S J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1317-1320. PubMed ID: 29127768 [TBL] [Abstract][Full Text] [Related]
24. Higher-Than-Conventional Subcutaneous Regular Insulin Doses Following Diabetic Ketoacidosis in Children and Adolescents. Bağ Ö; Tunç S; Nalbantoğlu Ö; Ecevit Ç; Öztürk A; Özkan B; Demir K J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):132-137. PubMed ID: 28044993 [TBL] [Abstract][Full Text] [Related]
25. Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report. Nguyen AD; Luong CQ; Chu HC; Nguyen VKD; Nguyen CV; Nguyen TA; Nguyen QH; Mai TD; Nguyen DV; Nguyen BQ; Tran TH; Dao PV; Nguyen DT; Nguyen NN; Do SN BMC Endocr Disord; 2019 Nov; 19(1):121. PubMed ID: 31711488 [TBL] [Abstract][Full Text] [Related]
26. Utilizing serum bicarbonate instead of venous pH to transition from intravenous to subcutaneous insulin shortens the duration of insulin infusion in pediatric diabetic ketoacidosis. Gauntt J; Vaidyanathan P; Basu S J Pediatr Endocrinol Metab; 2019 Jan; 32(1):11-17. PubMed ID: 30530908 [TBL] [Abstract][Full Text] [Related]
27. Computer-Based versus Paper-Based Insulin Infusion Algorithms in Diabetic Ketoacidosis. Younis M; Pham J; Asad H; Hamarshi MS Curr Diabetes Rev; 2020; 16(6):628-634. PubMed ID: 31538900 [TBL] [Abstract][Full Text] [Related]
28. A case of Rabson-Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney. Abe Y; Sato T; Takagi M; Watanabe T; Nagayama Y; Hasegawa T; Abe T J Pediatr Endocrinol Metab; 2012; 25(5-6):587-90. PubMed ID: 22876563 [TBL] [Abstract][Full Text] [Related]
30. Serum glucose changes during insulin therapy in pediatric patients with diabetic ketoacidosis. Bradley P; Tobias JD Am J Ther; 2007; 14(3):265-8. PubMed ID: 17515702 [TBL] [Abstract][Full Text] [Related]
31. Effects of long-acting somatostatin analogue (Sandostatin) on manifest diabetic ketoacidosis. Yun YS; Lee HC; Park CS; Chang KH; Cho CH; Song YD; Lim SK; Kim KR; Huh KB J Diabetes Complications; 1999; 13(5-6):288-92. PubMed ID: 10765004 [TBL] [Abstract][Full Text] [Related]
32. [Insulin receptor defect as a cause of Rabson-Mendenhall syndrome and other rare genetic insulin resistance syndromes]. Rojek A; Niedziela M Pediatr Endocrinol Diabetes Metab; 2010; 16(3):205-12. PubMed ID: 21092701 [TBL] [Abstract][Full Text] [Related]
33. Euglycemic diabetic ketoacidosis in pregnancy. Tarif N; Al Badr W Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):590-3. PubMed ID: 17951948 [TBL] [Abstract][Full Text] [Related]
34. Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. Goyal N; Miller JB; Sankey SS; Mossallam U J Emerg Med; 2010 May; 38(4):422-7. PubMed ID: 18514472 [TBL] [Abstract][Full Text] [Related]
35. Management challenges of Rabson Mendenhall syndrome in a resource limited country: a case report. Aftab S; Shaheen T; Asif R; Anjum MN; Saeed A; Manzoor J; Cheema HA J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1429-1432. PubMed ID: 36106528 [TBL] [Abstract][Full Text] [Related]
36. Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis? Kitabchi AE; Murphy MB; Spencer J; Matteri R; Karas J Diabetes Care; 2008 Nov; 31(11):2081-5. PubMed ID: 18694978 [TBL] [Abstract][Full Text] [Related]
37. Impact of diabetic ketoacidosis management in the medical intensive care unit after order set implementation. Laliberte B; Yeung SYA; Gonzales JP Int J Pharm Pract; 2017 Jun; 25(3):238-243. PubMed ID: 28338247 [TBL] [Abstract][Full Text] [Related]
38. Does Management of Diabetic Ketoacidosis with Subcutaneous Rapid-acting Insulin Reduce the Need for Intensive Care Unit Admission? Cohn BG; Keim SM; Watkins JW; Camargo CA J Emerg Med; 2015 Oct; 49(4):530-8. PubMed ID: 26238182 [TBL] [Abstract][Full Text] [Related]
39. New approaches to the use of insulin in patients with diabetic ketoacidosis. Barski L; Kezerle L; Zeller L; Zektser M; Jotkowitz A Eur J Intern Med; 2013 Apr; 24(3):213-6. PubMed ID: 23395363 [TBL] [Abstract][Full Text] [Related]